Robeco Institutional Asset Management
ENTA icon

Robeco Institutional Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Robeco Institutional Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-861
Closed -$41K – 945
2022
Q2 		$41K Hold
861
– – ﹤0.01% 904
2022
Q1 		$61K Hold
861
– – ﹤0.01% 896
2021
Q4 		$64K Buy
+861
New +$67.6K ﹤0.01% 886
2019
Q4 		– Sell
-791
Closed -$48K – 977
2019
Q3 		$48K Buy
+791
New +$58.8K ﹤0.01% 946

Other funds holding ENTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Robeco Institutional Asset Management's ENTA Position: Q3 2022 in Review

Robeco Institutional Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q3 2022, closing a stake of 861 shares — an estimated $41K sold.

Robeco Institutional Asset Management first reported a position in ENTA in Q3 2019 and held it in 4 quarters. The position peaked at $64K in Q4 2021. 160 funds tracked by Wall St. Rank hold ENTA as of Q3 2022.

  • Robeco Institutional Asset Management reported no remaining Enanta Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 861 Enanta Pharmaceuticals shares in Q3 2022, an estimated $41K.
  • Robeco Institutional Asset Management first reported a position in Enanta Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Robeco Institutional Asset Management's Enanta Pharmaceuticals position peaked at $64K in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2022.

Based on Robeco Institutional Asset Management's 13F filing for Q3 2022, filed 27 Oct 2022.